A Pilot Study on the Efficacy of Lactobacillus Brevis CD2 Lozenges in Preventing Oral Mucositis by High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation

Giammarco, S., Chiusolo, P., Di Giovanni, A., Metafuni, E., Sica, S., Iavarone, F., et al ...
Leggi Tutto

Multi-Sensor Approach for the Monitoring of Halitosis Treatment via Lactobacillus brevis (CD2)—Containing Lozenges—A Randomized, Double-Blind Placebo-Controlled Clinical Trial

Marchetti, E., Tecco, S., Santonico, M., Vernile, C., Ciciarelli, D., Tarantino, E., et al. Abstract ...
Leggi Tutto

Modulation of the host response by probiotic L actobacillus brevis CD 2 in experimental gingivitis

Lee, J.-K., Kim, S.-J., Ko, S.-H., Ouwehand, A. C., & Ma, D. S. Abstract Objective ...
Leggi Tutto

Effects of vaginal lactobacilli in Chlamydia trachomatis infection

Mastromarino, P., Di Pietro, M., Schiavoni, G., Nardis, C., Gentile, M., & Sessa, R. (2014) ...
Leggi Tutto

Topical treatment with probiotic Lactobacillus brevis CD 2 inhibits experimental periodontal inflammation and bone loss

Maekawa, T., & Hajishengallis, G. Abstract Background and Objective - An increasing body of evidence ...
Leggi Tutto